Literature DB >> 33507371

Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4.

Francisco Grandas1, Manuel Desco2,3,4,5, Francisco J Navas-Sánchez6,7, Alberto Fernández-Pena2, Daniel Martín de Blas2, Yasser Alemán-Gómez8,9,10, Luís Marcos-Vidal2,3,10, Juan A Guzmán-de-Villoria2,3,11, Pilar Fernández-García12, Julia Romero2,11, Irene Catalina1, Laura Lillo13,14, José L Muñoz-Blanco1, Andrés Ordoñez-Ugalde15,16,17, Beatriz Quintáns18,19,20, Julio Pardo21, María-Jesús Sobrido18,22, Susanna Carmona2,3.   

Abstract

SPG4 is an autosomal dominant pure form of hereditary spastic paraplegia (HSP) caused by mutations in the SPAST gene. HSP is considered an upper motor neuron disorder characterized by progressive spasticity and weakness of the lower limbs caused by degeneration of the corticospinal tract. In other neurodegenerative motor disorders, the thalamus and basal ganglia are affected, with a considerable impact on disease progression. However, only a few works have studied these brain structures in HSP, mainly in complex forms of this disease. Our research aims to detect potential alterations in the volume and shape of the thalamus and various basal ganglia structures by comparing 12 patients with pure HSP and 18 healthy controls. We used two neuroimaging procedures: automated segmentation of the subcortical structures (thalamus, hippocampus, caudate nucleus, globus pallidus, and putamen) in native space and shape analysis of the structures. We found a significant reduction in thalamic volume bilaterally, as well as an inward deformation, mainly in the sensory-motor thalamic regions in patients with pure HSP and a mutation in SPG4. We also observed a significant negative correlation between the shape of the thalamus and clinical scores (the Spastic Paraplegia Rating Scale score and disease duration). Moreover, we found a 'Group × Age' interaction that was closely related to the severity of the disease. No differences in volume or in shape were found in the remaining subcortical structures studied. Our results suggest that changes in structure of the thalamus could be an imaging biomarker of disease progression in pHSP.

Entities:  

Keywords:  Atrophy; Biomarkers; Neuroimaging; Spastic paraplegia; Thalamus

Year:  2021        PMID: 33507371     DOI: 10.1007/s00415-020-10387-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  60 in total

Review 1.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks.

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Gabriel Novaes de Rezende Batistella; Thiago Bortholin; Acary Souza Bulle Oliveira
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

2.  De novo SPAST mutations may cause a complex SPG4 phenotype.

Authors:  Jolanda H Schieving; Susanne T de Bot; Laura A van de Pol; Nicole I Wolf; Eva H Brilstra; Suzanna G Frints; Judith van Gaalen; Mala Misra-Isrie; Maartje Pennings; Corien C Verschuuren-Bemelmans; Erik-Jan Kamsteeg; Bart P van de Warrenburg; Michèl A Willemsen
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

3.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

4.  Reduced regional cerebral blood flow in SPG4-linked hereditary spastic paraplegia.

Authors:  Kristin H Scheuer; Jørgen E Nielsen; Katja Krabbe; Carina Simonsen; Pernille Koefoed; Sven A Sørensen; Anders Gade; Olaf B Paulson; Ian Law
Journal:  J Neurol Sci       Date:  2005-08-15       Impact factor: 3.181

Review 5.  Hereditary spastic paraplegia SPG4: what is known and not known about the disease.

Authors:  Joanna M Solowska; Peter W Baas
Journal:  Brain       Date:  2015-06-20       Impact factor: 13.501

Review 6.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

7.  Resting state fMRI studies in SPG4-linked hereditary spastic paraplegia.

Authors:  Xinxin Liao; Mufang Huang; Wu Xing; Xinwei Wu; Weihua Liao; Xiaoyi Wang; Beisha Tang; Lu Shen
Journal:  J Neurol Sci       Date:  2017-10-28       Impact factor: 3.181

Review 8.  Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms.

Authors:  Temistocle Lo Giudice; Federica Lombardi; Filippo Maria Santorelli; Toshitaka Kawarai; Antonio Orlacchio
Journal:  Exp Neurol       Date:  2014-06-20       Impact factor: 5.330

9.  Multimodal MRI-based study in patients with SPG4 mutations.

Authors:  Thiago J R Rezende; Milena de Albuquerque; Gustavo M Lamas; Alberto R M Martinez; Brunno M Campos; Raphael F Casseb; Cynthia B Silva; Lucas M T Branco; Anelyssa D'Abreu; Iscia Lopes-Cendes; Fernando Cendes; Marcondes C França
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Mutations in the SPAST gene causing hereditary spastic paraplegia are related to global topological alterations in brain functional networks.

Authors:  Rosaria Rucco; Marianna Liparoti; Francesca Jacini; Fabio Baselice; Antonella Antenora; Giuseppe De Michele; Chiara Criscuolo; Antonio Vettoliere; Laura Mandolesi; Giuseppe Sorrentino; Pierpaolo Sorrentino
Journal:  Neurol Sci       Date:  2019-02-08       Impact factor: 3.307

View more
  1 in total

1.  Tract-specific damage at spinal cord level in pure hereditary spastic paraplegia type 4: a diffusion tensor imaging study.

Authors:  Francisco Grandas; Manuel Desco; Francisco J Navas-Sánchez; Luis Marcos-Vidal; Daniel Martín de Blas; Alberto Fernández-Pena; Yasser Alemán-Gómez; Juan A Guzmán-de-Villoria; Julia Romero; Irene Catalina; Laura Lillo; José L Muñoz-Blanco; Andrés Ordoñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanna Carmona
Journal:  J Neurol       Date:  2022-01-09       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.